{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:24:37Z","timestamp":1785183877331,"version":"3.55.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Hyperuricemia, pulmonary hypertension, and renal failure in infancy and alkalosis syndrome (HUPRA syndrome) is an ultrarare mitochondrial disease that is characterized by hyperuricemia, pulmonary hypertension, renal failure, and alkalosis. Seryl-tRNA synthetase 2 (<jats:italic>SARS2<\/jats:italic>) gene variants are believed to cause HUPRA syndrome, and these variants result in the loss of function of seryl-tRNA synthetase. Eventually, mutated seryl-tRNA synthetase is unable to catalyze tRNA synthesis and leads to the inhibition of the biosynthesis of mitochondrial proteins. This causes oxidative phosphorylation (OXPHOS) system impairments. To date, five mutation sites in the <jats:italic>SARS2<\/jats:italic> gene have been identified. We used whole-exome sequencing and Sanger sequencing to find and validate a novel compound heterozygous variants of <jats:italic>SARS2<\/jats:italic> [c.1205G&amp;gt;A (p.Arg402His) and c.680G&amp;gt;A (p.Arg227Gln)], and <jats:italic>in silico<\/jats:italic> analysis to analyze the structural change of the variants. We found that both variants were not sufficient to cause obvious structural damage but changed the intermolecular bond of the protein, which could be the cause of HUPRA syndrome in this case. We also performed the literature review and found this patient had significant pulmonary hypertension and minor renal dysfunction compared with other reported cases. This study inspired us to recognize HUPRA syndrome and broaden our knowledge of gene variation in PH.<\/jats:p>","DOI":"10.3389\/fcvm.2022.1058569","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T08:53:27Z","timestamp":1673254407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel variants of seryl-tRNA synthetase resulting in HUPRA syndrome featured in pulmonary hypertension"],"prefix":"10.3389","volume":"9","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunbin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1172\/JCI120847","article-title":"Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains.","volume":"128","author":"Culley","year":"2018","journal-title":"J Clin Invest."},{"key":"B2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajhg.2010.12.010","article-title":"Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome.","volume":"88","author":"Belostotsky","year":"2011","journal-title":"Am J Hum Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1038\/sj.emboj.7600811","article-title":"Dual-mode recognition of noncanonical tRNAs(Ser) by seryl-tRNA synthetase in mammalian mitochondria.","volume":"24","author":"Chimnaronk","year":"2005","journal-title":"EMBO J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.7150\/thno.43622","article-title":"Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.","volume":"10","author":"Zou","year":"2020","journal-title":"Theranostics."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05560-y","article-title":"A case of chronic kidney disease with pulmonary hypertension, hyperuricemia, immunodeficiency and other extrarenal findings: answers.","author":"G\u00f6knar","year":"2022","journal-title":"Pediatr Nephrol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-195","article-title":"A new mutation in the gene encoding mitochondrial seryl-tRNA synthetase as a cause of HUPRA syndrome.","volume":"14","author":"Rivera","year":"2013","journal-title":"BMC Nephrol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1650","article-title":"Novel SARS2 variants identified in a Chinese girl with HUPRA syndrome.","volume":"9","author":"Zhou","year":"2021","journal-title":"Mol Genet Genomic Med."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215804","article-title":"Prevalence of intellectual and developmental disabilities among first generation adult newcomers, and the health and health service use of this group: a retrospective cohort study.","volume":"14","author":"Durbin","year":"2019","journal-title":"PLoS One."},{"key":"B9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data.","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet."},{"key":"B10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome.","volume":"47","author":"Rentzsch","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159001","article-title":"Preventing data ambiguity in infectious diseases with four-dimensional and personalized evaluations.","volume":"11","author":"Iandiorio","year":"2016","journal-title":"PLoS One."},{"key":"B13","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/humu.23021","article-title":"Splicing defect in mitochondrial Seryl-tRNA synthetase gene causes progressive spastic paresis instead of HUPRA syndrome.","volume":"37","author":"Linnankivi","year":"2016","journal-title":"Hum Mutat."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-017-0477-4","article-title":"Salidroside attenuates hypoxia-induced pulmonary arterial smooth muscle cell proliferation and apoptosis resistance by upregulating autophagy through the AMPK-mTOR-ULK1 pathway.","volume":"17","author":"Gui","year":"2017","journal-title":"BMC Pulm Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"13394","DOI":"10.1073\/pnas.1821401116","article-title":"PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.","volume":"116","author":"Cao","year":"2019","journal-title":"Proc Natl Acad Sci USA."},{"key":"B16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-physiol-031620-123956","article-title":"Metabolism in pulmonary hypertension.","volume":"83","author":"Xu","year":"2021","journal-title":"Annu Rev Physiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000991","article-title":"Phosphorylation of seryl-tRNA synthetase by ATM\/ATR is essential for hypoxia-induced angiogenesis.","volume":"18","author":"Shi","year":"2020","journal-title":"PLoS Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ebiom.2018.06.003","article-title":"IL-33 initiates vascular remodelling in hypoxic pulmonary hypertension by up-regulating HIF-1\u03b1 and VEGF expression in vascular endothelial cells.","volume":"33","author":"Liu","year":"2018","journal-title":"Ebiomedicine."},{"key":"B19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cca.2018.05.046","article-title":"Uric acid and cardiovascular disease.","volume":"484","author":"Ndrepepa","year":"2018","journal-title":"Clin Chim Acta."},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00332-2020","article-title":"Serum and pulmonary uric acid in pulmonary arterial hypertension.","volume":"58","author":"Savale","year":"2021","journal-title":"Eur Respir J."},{"key":"B21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.critrevonc.2018.10.003","article-title":"Congenital neutropenia and primary immunodeficiency diseases.","volume":"133","author":"Spoor","year":"2019","journal-title":"Crit Rev Oncol Hematol."},{"key":"B22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00415-015-7884-3","article-title":"Mitochondrial disease: genetics and management.","volume":"263","author":"Ng","year":"2016","journal-title":"J Neurol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1058569\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T08:54:01Z","timestamp":1673254441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1058569\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":22,"alternative-id":["10.3389\/fcvm.2022.1058569"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1058569","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"article-number":"1058569"}}